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Amphiphilic block copolymers containing 
poly(dimethylsiloxane), poly(ethy1ene ox- 
ide), and heparin (PDMS-PEO-Hep) have 
been prepared via a series of coupling reac- 
tions using functionalized prepolymers, di- 
isocyanates, and derivatized heparins. All 
intermediate steps of the synthesis yield 
quantifiable products with reactive end- 
groups, while the final products demon- 
strate bioactive, covalently bound heparin 
moieties. Due to the solvent systems re- 
quired, commercial sodium heparin was 
converted to its benzyltrimethyl ammo- 
nium salt to enhance its solubility. The 
same procedure was applied to heparin 
degraded by nitrous acid in order to co- 
valently couple it in solutiions with the 
semitelechelic copolymers. As might be 
expected, this derivatization reduces the 
apparent bioactivity of the heparin. How- 
ever, preliminary findings suggest that the 
bioactivity can be restored by reforming 
the heparin sodium salt. 
INTRODUCTION 
Since their commercialization in 1943, silicone polymers have shown sig- 
nificant and widespread success as biomaterials in implant and pharma- 
ceutical applications. Historically, silicone rubbers were thought to exhibit 
promising, acceptable nonthrombogenic behavior because of their hydro- 
phobic character. These materials were applied early in contact lens de- 
velopment because of their high oxygen permeabilities. Later, improved 
biomedical properties were sought by modifying silicones, either by in situ 
surface modification to increase hydr~philicity,'-~ or more recently, by modi- 
fying chemical constituents of the silicone polymer by incorporating polar 
groups into monomers and prepolymers.& 
New research literature describing the ~ y n t h e s i s ~ - ~  and commercial 
availability" of derivatized, functionalized siloxanes now offers ready access 
to a versatile array of reactive silicone prepolymers to modify and prepare 
new biomaterials. 
Amphiphilic copolymers composed of hydrophilic and hydrophobic 
blocks have demonstrated unique properties and behaviors in biomaterials 
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 application^."-'^ Amphiphilic copolymers containing a third, pharma- 
ceutically active block of heparin have also been synthesized and character- 
ized.lS The aim of the work was to provide a blood-compatible, heparinized 
coating to improve the surface properties of existing polymer substrates 
without changing the bulk properties. The triblock coating idea, as idealized 
in possible morphologies in Figure 1, incorporates hydrophobic poly- 
(dimethylsiloxane) together with the promising hemocompatible advantages 
of poIy(ethy1ene oxide)I6 and the anticoagulant properties of heparin to yield 
a coatable system where the hydrophobic block may be anchored into a 
suitable, existing hydrophobic substrate and the hydrophilic block acts as 
solubilizable tether to the covalently bound heparin moiety (Figure 1, middle 
model). However, coating may bury PEO chains or promote phase sepa- 
ration of the hydrophobic and hydrophilic blocks, creating a heterogeneous 
surface containing heparin but without the effect of a solubilized hydrophilic 
spacer (Figure 1, left and right models). In any case, such a system of 
immobilized anticoagulant provides a localized, permanent nonthrom- 
bogenic environment and avoids the problems associated with systemically 
administered heparin. It has been demonstrated, however, that heparinized 
coatings lose various degrees of bioactivity unless the heparin group is 
immobilized away from the surface by a spacer group. Systems employing 
directly immobilized heparinsI7 have shown that while these heparinized 
surfaces bind thrombin and Factor Xa, the immobilized heparin was not able 
to inhibit their activity, suggesting a sensitivity to sites and modes of attach- 
ment. More specifically, immobilized heparin interactions with coagulation 
factors increase as bound heparin is moved away from the surface into a 
more bulklike plasma environment and appear to be dependent upon tether 
arm length." Spacer groups may permit increased exposure of heparin's 
binding sites for ATIII and thrombin to plasma. 
This paper presents the initial results of synthesis and characterization of 
a block copolymer consisting of hydrophobic poly( dimethylsiloxane), hydro- 
philic poly(ethy1ene oxide), and pharmacologically active heparin. A detailed 
evaluation of the bioactivity of this material as a coating in vitro is presented 
in a following paper.I9 
Three Possible Surface Morphologies for Block Copolymers of PDMS-PEO-Heparin 
A B C  A A B  
Figure 1. 
(dimethylsiloxane), poly(ethy1ene oxide), and heparin. 
Possible surface morphologies for block copolymers of poly- 
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Materials 
Pulytdimethylsiloxanes) (PDMS): Functionalized prepolymers of PDMS were 
used as supplied by Petrarch Systems Inc. (Bristol, PA, USA). Mono- 
functionalized amino-PDMS (M, = 9500 (ref. 20)) and methyl-hydro PDMS 
containing 0.5%-1.0% reactive Si-H groups (M, = 63,000) were stored at -20°C 
under nitrogen. 
PohJethyfene oxides) (PEO): Diamino-telechelic poly(ethy1ene oxides) under the 
trade name Jeffamines were a gift from Texaco Chemical Company (Houston, 
TX, USA). Jeffamine 6000 (M,, = 6000) was purified by dissolving in THF, pre- 
cipitating in a 10-fold excess of diethyl ether two separate times, drying under 
vacuum over P,O,, and finally drying in zlacuo at 70°C for 2 hr. Diamino- 
telechelic PEO (M, = 4000) was a generous gift from Nippon Oil & Fats Ltd. 
(Tokyo, Japan) and was used as supplied. 
Heparin: Commercial heparin (Diosynth, Oss, The Netherlands) with an activ- 
ity of 165.4 IU/mg as indicated by the manufacturer was subject to chemical 
modifications, assayed for bioactivity, and utilized. Tritium-labeled heparin 
(6.3 mg, New England Nuclear, Boston, MA, USA) with a specific activity to 
158 pCi/mg was diluted with 10 mL water, purified by chromatography and 
utilized. 
Toluene 2,4-diisocyanate (TDI, Fluka Chemika, Buchs, Switzerland) was puri- 
fied by distillation at reduced pressure under nitrogen and the fraction at 
126"C/11 mmHg collected and stored under nitrogen at 4°C. 
Methylene diphenyl diisocyanate (MDI) (Merck, Darmstadt, FRG) was pun- 
fied by distillation at 3 mmHg. A yellow-white solid (m.p. = 38-40°C) was 
stored under nitrogen at -20°C. 
Toluene and tetrahydrofuran (THF) were dried over CaC12 and distilled by 
conventional means. 
Chloroform was purified by elution through a column of activated aluminum 
oxide (100 g/L, basic, Janssen Chimica, Beerse, Belgium) and the fraction from 
50-800 mL stored in an amber bottle under nitrogen at -20°C. 
Chloroplatinic acid (H,PtCI,, solid, Janssen Chimica, Beerse, Belgium) was 
dissolved in freshly distilled N,N-dimethylformamide (DMF) under a nitrogen 
blanket and stored at reduced temperature (1.0% w/v). 
Benzyltrimethylammonium bromide (Triton B, Fluka Chemika, Buchs, Swit- 
zerland) was used as received. 
Sodium cyanoborohydride, allyl alcohol, and allyl isocyanate (Aldrich Chem- 
icals, Brussels, Belgium) and l-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC, Merck) were used as received and stored under nitrogen 
at reduced temperature. 
Diphenyl guanidine (DPG, Janssen Chimica, Beerse, Belgium) was purified 
according to the technique of Carlton and coworkers." 
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Synthesis 
Amino-semitelechelic poly(dimethylsi1oxane)-poly(ethy1ene oxide) block copolymers 
(PDMS -PEO -NH2) 
PDMS - PEO - NH2 block copolymers [ 51 were synthesized by a pro- 
cedure analogous to that used to prepare poly~tyrene-HEMA",~~ and 
polystyrene-poly(ethy1ene oxide)I5 block copolymers. The overall scheme 
involves a coupling reaction between isocyanate-semitelechelic PDMS 
[ PDMS - N = C = 0 , 3 ]  and amino-telechelic PEO [ H2N - PEO - NH2, 41. 
PDMS - N = C = 0 [3] was prepared by the following procedure: 
PDMS-NH2 ([l], 15% w/v in toluene) was added dropwise to a solution of 
TDI [2a] or MDI [2b] (2% w/v) in toluene over a period of 24 hr until a final 
ratio of [NH2]/[NCO] = 0.5 was obtained. The reaction mixture was stirred 
constantly under nitrogen at room temperature. Unpurified aliquots of the 
reactions were vacuum dried and analyzed by IR spectroscopy and the 
products were compared to unreacted mixtures of the two species. 
PDMS -PEO - NH2 block copolymers [5] were synthesized by adding 
PDMS-N=C=O [3] solutions (15% w/v) in toluene dropwise over a 
period of 48 hr to a solution of H2N-PEO-NH2 [4] (15% w/v) in toluene 
until the final ratio of [NH2]/(NCO] was 2.4. This reaction was performed 
under nitrogen at room temperature. Reactions were terminated by utilizing 
a dual precipitation technique after evaporating toluene to 50% of its original 
volume. Unreacted PDMS-NH2 [I] was removed by precipitation of the 
reaction contents into a 10-fold excess (v/v) of diethyl ether, leaving a white 
powder consisting of a mixture of [4] and [5]. Unreacted PEO [4] was then 
removed by chopping the powder to small granules and stirring gently in a 
50-fold excess (w/v) of water for 3 hr. Filtration, rinsing, and freeze-drying 
yielded a spongy, white block copolymer solid. The polymer was used 
immediately or stored at -20°C. 
The entire reaction sequence was attempted unsuccessfully at both 0°C 
and 60°C in toluene. The PDMS phase precipitated as a cross-linked gel in 
the diisocyanate solution at the higher temperature while the PEO phase or 
PEO-PDMS complex precipitated out of solution at lower temperatures. 
Chloroform was also attempted as a solvent system at various temperatures 
but no products were identified. It is thought that residual ethanol present 
as a stabilizer in chloroform was not adequately removed by aluminum 
purification and is contaminating the diisocyanate. 
In addition, other functionalized PDMS prepolymers were utilized in at- 
tempts to couple PEO. Methyl-hydro-PDMS reported to contain 0.5-1.0% 
reactive Si-H groups" was reacted with allyl alcohol and allyl isocyanate in 
separate reactions in an attempt to produce the functionalized hydrosilation 
products via the addition reaction in the presence of a ~ a t a l y s t . ~ , ~ ~  Reactions 
catalyzed by chloroplatinic acid in various solvents and temperatures failed 
to produce quantifiable reaction products of PDMS- OH or PDMS-NCO 
as indicated by proton NMR. Other researchers have noted the inconsistent 
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reactivity of certain allyl derivatives in hydrosilation additions (allyl amine, 
allyl bromide) while others (allyl alcohol, N-dimethyl allyl amine) appear 
very reactive.' In the supplied PDMS prepolymer, multiplet signals at 
4.77 ppm, characteristic of the Si-H group, were not present, indicating that 
the functionality may have been contaminated (or too weak to detect). In 
addition, the triplet expected at 3.64 ppm' for the hydroxymethlyene prod- 
uct from allyl alcohol was not detected. Finally, quantifiable coupling reac- 
tions with functionalized PEO failed to occur. 
Poly(dimefhylsi1oxane)-poly(ethy1ene oxidekheparin block copolymers 
(PDMS -PEO -Hep) 
PDMS -PEO-Hep block copolymers [7,9] were synthesized via a cou- 
pling reaction of PDMS-PEO-NH2 block copolymers [5] with derivatized 
heparins [6,8]. Commercial heparin was subject to cation exchange with 
benzyltrimethyl ammonium bromide to yield the Triton-B form [6]. The cat- 
ion exchange procedure involves replacement of Na' cations in heparin with 
the more hydrophobic quarternary ammonium cation." The process entails 
addition of 3.5 g of Triton-B to an aqueous solution of heparin (2.3 g in 
150 mL water) at pH = 7.5. Refngeration for 16 hr is followed by dialysis 
against distilled water for 24 hr to remove low-molecular-weight salt and 
heparin fragments less than 5000 daltons. Repeating this entire operation 
three times followed by lyophilization provides a heparin salt with enhanced 
solubility in organic solvents but showing lower bioactivity. 
Derivatized heparin [8] was prepared by nitrous acid deg rada t i~n~~  fol- 
lowed by Triton-B treatment to yield an organically-soluble, bioactive hepa- 
rin containing one aldehyde group per molecule.26 This heparin form was 
coupled to PDMS - PEO - NH2 block copolymers [5b] by reductive ami- 
nation. Freshly prepared copolymer (2.0 g) was first dissolved in THF 
(45 mL) and water (11 mL) was then added slowly with brief sonication until 
a clear solution was obtained. Heparin [6] was dissolved separately in water 
(1.5 g in 12 mL) and THF (50 mL) dropped slowly to the solution with 
stirring at 37°C until a clear solution was obtained. The two solutions were 
mixed and brought to pH = 6.5 with 1N HCl or 1N NaOH. Sodium cyano- 
borohydride (NaCNBH3), was dissolved in water (150 mg in 1mL) and THF 
(5 mL) was added. This solution was then added to the copolymer-heparin 
solution. The reaction was stirred at room temperature for 7 days with 
100 mg NaCNBH, added on day 3 and day 5 and the pH maintained at 6.5. 
Reaction products were recovered by removing the THF by evaporation, 
lyophilization, and subsequent thorough rinsing of the white solid with 
water to remove unreacted heparin and reducing agent. 
Heparin [8] was coupled to the block copolymer system [5b] using EDC at 
room in the same THF : water solvent system as mentioned 
above. Fresh block copolymer (700 mg in 31 mL THF :water) was mixed with 
heparin [8] (350 mg. in 62 mL THF:water) at pH 5 for 24 hr with the EDC 
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added in 8 equal portions at 30-min intervals. The reaction was then adjusted 
to pH 7.5 for 24 hours with 1N NaOH. Finally, the reaction was terminated 
by removing the solvent by evaporation, lyophilization, and thorough rins- 
ing of the resulting solid with water to yield the block copolymer [9]. 
Tritium-labeled heparin was incorporated into the block copolymers using 
the following procedure: disposable Sephadex G-25M I'D-10 desalting col- 
umns (Pharmacia) were characterized for void volumes and dilution factors 
using Dextran Blue in water. Labeled heparin in water (3  mL, 300 pCi) was 
applied in 0.5-mL aliquots to the column and the eluent collected in 10 drop 
(approximately 0.5-mL) fractions. Fractions 7-10 corresponding to the high- 
est molecular weight heparin molecules were pooled and assayed for radio- 
activity. The same procedure was utilized to fractionate commercial heparin 
(600 mg in 6 mL water). Fractions 7-10 of the commercial heparin were 
lyophilized, weighed, and added directly to 5 mL of the radioactive pool and 
5 mL of distilled water to give a solution concentration of 17.0 mg/mL with 
a specific activity of 1.0 x lo6 dpm/mg. THF (25 mL) was added dropwise to 
the heparin solution at 37°C and this solution was mixed with a THF:water 
solution containing 500 mg of fresh block copolymer. A coupling reaction 
was then undertaken using the EDC method described above. After wash- 
ing with solvent, recovered product was assayed for radioactivity by dis- 
solution in THF: water and scintillation counting with an LKB 1219 Rackbeta 
instrument. 
Characterization 
Specf roscopy 
Infrared (IR) spectra of the prepolymers and block copolymers were ob- 
tained from films cast on sodium chloride crystals using a Perkin-Elmer 
1310 spectrophotometer. Proton NMR spectra were obtained from samples 
in chloroform-dl using a Varian EM360A instrument. Tetramethylsilane used 
for referencing peak shift locations downfield was found to interfere with 
proton integration of PDMS signals and therefore was used only occasionally 
to determine downfield shifts. 
Molecular weight 
Molecular weights (R,) of the prepolymers and block copolymers were 
determined by vapor pressure osmometry (VPO) (Hewlett Packard 301A) in 
toluene at 37°C. These results were compared with data from gel permeation 
chromatography (GPC) (Waters Model 600A HPLC and Waters Differential Re- 
fractometer R401), using ultrastyragel columns with exclusion limits of lOj, lo4, 
lo3, and 500 A in series. THF was used as a solvent at a flow rate of 2.02 mL/min 
at 21°C. 
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End-group analysis 
Amino group functionalization for the PDMS and PEO prepolymers as 
well as the PDMS-PEO copolymers was analyzed with potentiometric ti- 
tration. Polymer solutions in chloroform or DMF were titrated with 0.015N 
perchloric acid in dioxane. The titrant was standardized by titrating DPG in 
solutions of chloroform or DMF. 
Swelling measurements 
Solutions of PDMS-PEO-NH2 in chloroform (5% w/v) were cast into 
silanized petri dishes and air-dried for 24 hr followed by vacuum drying for 
24 hr. Films were removed, measured for thickness with a micrometer, and 
cut into pieces of identical geometry and size using a grid pattern. Film pieces 
were then weighed, immersed completely into solutions of water and moni- 
tored for swelling after 2 hr. Films were removed carefully from water, gently 
wiped dry with a dust-free towel and weighed. 
Heparins 
Prior to coupling reactions, derivatized heparins were compared to com- 
mercially supplied, unaltered heparin for bioactivity using activated-partial 
thromboplastin time (APTT) assays. Heparin solutions (0.05 mL) in water 
were incubated for 5 min at 37°C with 0.1 mL citrated fresh-frozen human 
plasma pooled from healthy donors. CephaliniKaolin activating reagent 
was added and incubated an additional 3 min before CaCI2 was added to 
coagulate the samples. Clot formation was detected optically and auto- 
matically with a Lode Coagulatometer (Model LC-6, Lode, Groningen, The 
Netherlands). 
RESULTS AND DISCUSSION 
The synthetic outline for the block copolymer chemistry is shown in 
Figure 2. Semitelechelic-isocyanated PDMS was prepared using both MDI 
and TDI in solution coupling reactions. IR spectroscopy, shown in Figure 3, 
demonstrates evidence for urea bond formation in this reaction by the pres- 
ence of N-H stretch at 3320 cm-1, Amide I at 1645 cm-1 and Amide I1 at 
1540 cm-1. These peaks appeared for both the MDI and TDI func- 
tionalizations and were not present in simple mixtures of the PDMS and 
diisocyanates. A strong adsorption at 2270 cm-1 is characteristic of the free 
isocyanate group. When these isocyanated prepolymers were coupled to 
amino-telechelic PEO, IR scans, shown in Figure 4, demonstrate new N--H 
stretching absorbance shifts at 3520 and 3380 cm-1 as well as Amide I and I1 
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\ Hep'-H PDMS-PEO-NHCH2-Hep 191 
NaCNBH3 
[2b]. [3bl, [5b] ' R = f i%iO 
[6] and [S] Trrlon-Bsail 
I41 PEO (Mn =4000 and 6OOO) 
Figure 2. Synthetic scheme for PDMS-PEO-heparin block copolymers. 
t I I I 1 1 I I 1 I I  
m 3003 2030 1800 1400 loo0 600 
Overlayed infrared spectra for PDMS-NH, (A), PDMS-TDI (B), Figure 3. 
and PDMS-MDI (C). 
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Figure 4. 
PEO-NH2 (B), and PDMS-MDI-PEO-NH, (C). 
Overlayed infrared spectra for H2N-PEO-NHL (A), PDMS-TDI- 
peaks at 1670 and 1540 cm-1, respectively. The prominent isocyanate peak 
disappears as well. This information indicates the formation of urea linkages 
between PDMS and PEO into two different chemical environments. 
Proton NMR analysis shows the presence of both PDMS and PEO compo- 
nents as displayed in Figure 5 (siloxane backbone: 0.1 ppm and methylene- 
ether backbone: 3.4-3.8 ppm). Integration of the signals confirms the proper 
ratio of protons in the block copolymer constituents (mole70 PDMS: calcu- 
lated 67%, found 6770). 
Molecular weight distributions of the synthesized block copolymers and 
prepolymers were determined using GPC. The most widely accepted pa- 
rameter defining elution volume in GPC is the theoretical quantity, hy- 
drodynamic volume. Under certain specified conditions, the relationship 
between hydrodynamic volume and elution volume has been shown to be 
independent of polymer type and structure over a wide range of polymer 
types with some exceptions. Thus, unknown species are typically calibrated 
against well-characterized polystyrene standards for molecular weight distri- 
bution  determination^.^' However, polystyrene standards used to make a 
calibration reference for GPC measurements in general, and for the PDMS- 
PEO-Hep system in particular, may not accurately relate to retention vol- 
umes of the PDMS for direct molecular weight determinations.'" Thus, GPC 
information for the pre- and heparinized block polymers containing PDMS 
was used only qualitatively to assess polydispersity. GI'C plots for both the 
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I I I I I  I 1  111-  
Figure 5. Proton-NMR spectra for PDMS-PEO-NHz Copolymer (a = 
polyether backbone, 3.6 ppm, b = siloxane backbone, 0.1 ppm). 
8 1 6 5 4 3 2 1 0  
prepolymers and the block copolymers are shown in Figure 6 and accom- 
panying molecular weight data are displayed in Table I. PEO prepolymers 
show quite a narrow distribution of molecular weights while PDMS shows 
a broad, plateau-like distribution. The copolymer products show a molecular 
weight distribution expected for the reaction of the two characterized 
prepolymers- broadly distributed over a range of values much like its 
Figure 6 .  GPC profiles for molecular weight distributions for HzN-PEO-NH2 
(A) PDMS-NHz (B), PDMS-PEO-(4000)-NH2 (C), and PDMS-PEO(6000)- 
NHz (D). 
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PDMS precursors. Copolymers, in general, have a distribution of chemical 
compositions associated with their molecular weight distribution. Since GPC 
separates molecules based on their size in solution, not according to molec- 
ular weight directly, exact molecular weight correlations and distributions for 
copolymers are difficult to assign between polystyrene standards and 
PDMS.31 The fact that retention volumes between polystyrene and PDMS 
cannot be compared directly (or even with a derived Q value”) makes it 
appropriate to use GPC data reported here for PDMS-containing compounds 
only for distribution information. 
Osmometry data from solutions of polymers in toluene is shown in Table I 
for comparison. In general, agreement between VPO and commercial claims 
is relatively good except for the anomalies with the PDMS prepolymer. Given 
the GPC evidence for low molecular weight contaminants present in the 
sample, it is reasoned the VPO results could easily indicate lower molecular 
weights than expected due to contaminant effects on colligative properties. 
GPC data, corrected using calculated Q values, demonstrates a few discrep- 
ancies as well, perhaps due to the problems mentioned. Overall, however, 
molecular weight characterization agrees well with expected copolymer 
results and demonstrates successful reaction products, even if broadly dis- 
persed. These data, together with NMR integral ratios, indicates that cou- 
pling reactions in the desired stoichiometry has been accomplished. In 
addition, end-group analysis, shown in Table I, demonstrates the existence 
of viable functional amino groups in all steps of the synthesis procedure. 
This adds strength to the assertion that the desired stoichiometric products 
were recovered. 
For swelling determinations to assess the copolymer’s behavior in aqueous 
conditions, films of the copolymers were cast from chloroform solutions onto 
silanized glass plates. The unheparinized block copolymer containing the 
PEO 4000 yielded a rubbery, flexible, translucent film lacking tear resistance 
but otherwise tough. Copolymers containing I’EO 6000 yielded pasty, white 
films lacking mechanical strength and were not used in swelling mea- 
surements. The strengths of both types of films appeared to improve with 
increased exposure time to air, indicating some siloxane vulcanization may 
be occurring. Thickness of the films, averaged from random measurements 
was approximately 13.5 pm in the dry state. Pieces measuring 2 x 2 cm 
turned to a gray color and lost their rigidity immediately on contact with 
water. After 2 hr of hydration, the films demonstrated nearly 350% (*40%) 
absorption of water by weight. Measurements after 4 hr were not possible 
due to loss of mechanical integrity. It appears as though the PEO phase 
maintains a dominant influence on the physical properties of the copolymer. 
This has various implications for coating behaviors. Both visual observation 
and clotting time results demonstrated that the coating on glass and PDMS 
remained intact in aqueous media. Nevertheless, swelling of the coatings 
probably did occur, possibly allowing the hydrophilic PEO and heparin 
phases increased exposure to an aqueous environment. 
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Other effects upon polymer mechanical strengths were qualitatively 
noted. Generally, copolymers containing TDI as a coupling agent exhibited 
poorer mechanical strength in films than the same copolymers containing 
MDI as a coupling agent. Lyman and coworkers3’ have noted significant 
differences in physical properties of aromatic polyurethanes compared to 
their aliphatic analogues, purportedly due to chain stiffening from the pres- 
ence of aromatic rings. It is proposed that, for the PDMS-PEO system, MDI 
permits increased opportunity to form associations of orbital complexes be- 
tween phenyl rings in adjacent chains, Increased chain mobilities from rota- 
tions around the methylene group between MDI’s phenyl rings may permit 
reorganization to maximize hydrogen bond effects. TDI formulations of 
PDMS-PEO may be sterically hindered from forming r-orbital complexes 
because of the methyl group pendant from TDI’s aromatic ring. 
Derivatized heparins [6,8] were assayed for bioactivity using APTT and 
compared to commercial heparin before coupling reactions with the PDMS- 
PEO block copolymers. Figure 7 shows APTT results as standard curves for 
the different heparin preparations. Commercial heparin converted to its 
Triton B salt [6] shows an apparent activity comparable to 40% of its com- 
mercial sodium salt. Heparin degraded by nitrous acid displayed 36% of the 
bioactivity of its commercial precursor while heparin subject to both acid 
cleavage and Triton B exchange [8] retained only 15% of its original activity 
Other researchersz6 have reported that nitrous acid treatment had similar 
deleterious effects on heparin activity. It is significant to note that since 
Triton B bioactivity assays are performed by dilutions of stock heparin solu- 
tions prepared as weight concentrations, the Triton B salt would necessarily 
contain a higher weight percentage of salt per weight of heparin (Triton B 
cation M.W. = 150.25 compared to Na cation M.W. = 22.99). Thus, any 
weight of Triton B heparin would contain less heparin molecules (hence, less 
detected bioactivity) than an equivalent weight of the natural, commercial 
form. Unpublished evidencez4 suggests that a large majority of Na cations in 
heparin are replaced by the Triton B exchange. These preliminary results also 
suggest that enough Triton B may be substituted for sodium in heparin to 
nearly double the molecular weight of the resulting heparin salt as compared 
to the commercial form. It is our assertion therefore, that assuming some 
intermediate degree of cation substitution is achieved, a significant weight 
correction factor must be introduced when comparing the bioactivity of this 
salt with other heparin forms. In addition, Triton B itself is an inherent 
physiological toxin and, in practical application, Triton B heparin would 
require retransformation back to its sodium salt prior to implantation or 
blood exposure. This transformation occws readily and reversibly in aque- 
ous media. As shown in Figure 7, the Triton B salt of commercial heparin 
regained the majority of its original activity when transformed back to its 
sodium salt form by exchange with NaCl. Nitrous acid-degraded heparin 
regained 50% of its original derivatized potency after reexchange with 
sodium. A final consideration in analyzing the reduced Triton B heparin 
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Figure 7. APTT standard curves comparing bioactivities for commercial and 
derivatized heparins in sodium and Triton B salt forms (A = commercial 
sodium salt, = commercial sodium salt regenerated from its Triton B salt, 
H = Triton B salt of commercial sodium salt, 0 = nitrous acid-degraded 
commercial sodium salt, A = sodium salt of nitrous acid-degraded derivative 
regenerated from its Triton B salt, 0 = Triton B salt of nitrous acid-degraded 
commercial sodium salt). 
bioactivity is that dialysis purification removes the low-molecular-weight 
fragments of heparin which have been implicated in potentiating heparin 
activity33 and have been shown to have higher affinity for binding coagu- 
lation factors.34 
Heparin was coupled directly to block copolymers of PDMS - PEO -NH2 
via two synthetic routes. In the first, EDC was used to activate carboxylic 
groups present on heparin. Since heparin contains a negligible amount of 
amine groups (1 glucosamine residue per 4-6 heparin molecules as deter- 
mined by 2,3,6-trinitrobenzenesulfonic acid,35 the activated carboxyl groups 
are expected to react exclusively with the amines present on the block co- 
polymer, This method is based upon procedures described by Danishefsky 
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and coworkersz9 for coupling aminoethyl agarose to heparin as well as work 
by Hennink and coworkers2’ coupling albumin to heparin. 
Carbodiimide chemistry and applications have been reviewed by Rich and 
and Kurzer and D~uraghi-Zadeh.~’ Carbodiimides are very reactive 
species known to add to nucleophiles rapidly under acidic conditions as 
shown in Figure 8. In the case of heparin, EDC reacts first with the carboxylic 
group to form the 0-acylisourea, a highly-activated acylating intermediate. 
Reactions of carbodiimides with carboxylic acids can also be catalyzed by acid 
in organic solvents which makes the THF : water system used here viable. 
The disadvantage of the carbodiimide method is the many accompanying 
side reactions leading to undesired products, chiefly N-acylureas. Reaction 
conditions favoring intermolecular nucleophilic attack on the 0-acylisourea 
lead to fewer side reactions. Unfortunately, reactions in solvents of low 
dielectric constants suppress side reactions to N-acylureas more than reac- 
tants in high dielectric solvents.36 The THF : water system used to couple 
PDMS-PEO to heparin is therefore not the optimum solvent system for 
reducing side reactions with EDC. 
Carbodiimides can also react with aliphatic amines such as those present 
on amino-telechelic PEO, directly to form guanidines by additions at high 
temperatures or via acidic catalysis. The question remains whether these two 
side reactions have been avoided by various researchers as well as these 
authors in preparing covalently bound heparin using the EDC method. 
Improvements in yields and anticoagulant potencies might be achieved by 
investigation into minimizing side reactions in this synthesis system. 
The anticoagulant activity of heparin in the block copolymer system is 
decreased from that of natural, unbound heparin. Work by various research- 
e r ~ ~ ~ ~  has shown that heparin’s bioactivity is sensitive to modification of its 
carboxylic groups, leading to a decrease in anticoagulant activity. Thus, the 
EDC reaction utilizing carboxylic moieties is expected to reduce heparin 
activity. In addition, it is possible that in the casting of PDMS-PEO-Hep onto 
substrates, the hydrophilic spacer of PEO and its attached heparin moiety 
may be partially or completely caught within the coating matrix. Since the 
system is designed as a coatable material, the effects of coating on bioactivity 
are a primary concern and are reported in a following paper.I9 Reactions with 
radiolabeled heparin demonstrate incorporation of only 3 mole% heparin 
into the copolymers using EDC. Side reactions described above could have 
reduced heparin coupling. Yields could also have been affected by the sen- 
sitivity heparin displays to the THF : water solvent system. Very small 
amounts of excess THF or water caused minor precipitation of the heparin 
or copolymer species respectively. Lastly, the fact that the radiolabeled hepa- 
B 
9 
p-C-Hep 
F$ -N=C=N R2 + Hep-C02H -& [R,.N=C.NH-%] PDMS-PEo-NH2) PDMS-PFO-NH-C-Hep 
E DC Heparin Block Polymer 
Figure 8. Carbodiimide reactions with carboxylic groups on heparin. 
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rin was not a Triton B salt may have resulted in its precipitation from solution 
and failure to couple to the copolymer. Because of the small amounts of 
radiolabeled species used, this could easily have escaped detection. 
In the second synthetic route, heparin was degraded by nitrous acid 
treatment to convert the 2-amino-2-deoxy-~-g~ucopyranosyl residues into 
2,5-anhydro-~-mannose residues with release of the aglycon.= The resulting 
aldehyde groups were reacted with primary amines onto PDMS-PEO co- 
polymers to give intermediate Schiff-bases convertable to the stable second- 
ary amine by r e d ~ c t i o n . ~ ~ , ~ ~ , ~  Specific reactions of aldehydes with primary 
amines such as those present on PDMS-PEO at pH 6-8 can be achieved in 
the presence of the BH3CN- anion leading to stable secondary amines via 
reductive amination of the carbonyl group.43," Thus, heparin-containing 
terminal aldehyde group (1 per molecule) by specific cleavage with nitrous 
acid was reacted with the amino-semitelechelic PDMS - PEO-NH2 block 
copolymers using NaCNBH3 as a selective reducing agent. Optimum condi- 
tions for this reaction, investigated by Solomon and coworkers,26 showed 
highest yields with 5% w/w NaCNBH3 at 50°C and unspecified pH. We 
believe these conditions to be deleterious to heparin bioactivity and are 
presently investigating optimum reaction conditions which maximize yield 
and minimize bioactivity losses. 
CONCLUSIONS 
Amino-semitelechelic poly(dimethylsi1oxane) (PDMS, [ l]), was coupled to 
diamino-telechelic poly(ehty1ene oxide) (PEO, [4]) using two different di- 
isocyanate species yielding block copolymers of PDMS- PEO-NH2 [5]. 
The terminal amino groups on this copolymer were then used to covalently 
bind heparin in two different procedures in THF: water solutions. In the first 
procedure, carboxylic acid groups on heparin were activated with EDC and 
subsequently coupled with the amino-semitelechelic PDMS - PEO - 
NH2 [5] to give the heparinized product [7]. In the second experiment, hepa- 
rin was first derivatized by acid hydrolysis to give heparin with aldehyde 
groups [8]. This heparin form was then coupled to the copolymer [5] via 
a Schiffs base complex (reductive amination) using NaCNBH3 as a selec- 
tive reducing agent. Both reactions yielded block copolymers in quantita- 
tive yields having bioactive heparin moieties. Incorporation of fractionated, 
radiolabeled heparin into the block copolymers using the EDC method indi- 
cated 3 mole% heparin content in the copolymer system. 
These results demonstrate the successful development of a new technique 
to improve the surface properties of biomaterials using a coatable amphi- 
philic copolymer system containing bioactive, covalently bound heparin. 
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